elliptinium has been researched along with Asialia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couette, JE; Delozier, T; Heron, JF; Juret, P; Le Talaer, JY | 1 |
| Azab, M; Le Chevalier, T; Mondésir, JM; Rouëssé, J; Spielmann, M; Turpin, F | 1 |
1 trial(s) available for elliptinium and Asialia
| Article | Year |
|---|---|
Phase II study of elliptinium acetate salvage treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Ellipticines; Female; Humans; Intercalating Agents; Middle Aged; Prospective Studies; Salvage Therapy; Xerostomia | 1993 |
1 other study(ies) available for elliptinium and Asialia
| Article | Year |
|---|---|
Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experience.
Topics: Alkaloids; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Digestive System; Drug Evaluation; Ellipticines; Female; Humans; Kidney; Xerostomia | 1982 |